Article
O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.
International journal of cancer - 10 Feb 2005
Watanabe Takao, Katayama Yoichi, Komine Chiaki, Yoshino Atsuo, Ogino Akiyoshi, Ohta Takashi, Fukushima Takao
Abstract excerpt
Epigenetic silencing of O(6)-methylguanine-DNA methyltransferase (MGMT) by promoter methylation can confer cancer cells with an increased sensitivity to alkylating chemotherapeutic agents and a higher susceptibility to TP53 transition mutations. The aim of our study was to assess the correlation of promoter methylation of the MGMT gene with TP53 mutations and the clinical characteristics of malignant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
